GTC Biotherapeutics (fka GTCB)

[medchal]

I agree that delisting would quite a way down the road: The NASDAQ has been very accommodating of late on the issue of share price. Furthermore, being moved to the bulletin boards does not suddenly make the company a non-reporting piece of junk.

However, I responded to the original post as I did because there is a large, unwashed sector of the investing public that likes to play around with penny stocks without knowing much about them or about the equity market in general. These folks are not noted for the ability to discriminate between Pink Sheets, the greys, the bulletin boards, non-reporting stocks, penny stocks, etc. It is my conclusion that GTCB, if it remained below $1.00 long enough to be removed from the NASDAQ list, might actually trade somewhat differently than it does now. I've seen it happen before.